KennethOffitMD

Professor, Medicine, Weill Cornell Medical College

Overview of Dr. Offit

Dr. Kenneth Offit is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Mount Sinai Morningside. He received his medical degree from Harvard Medical School and has been in practice 35 years. Dr. Offit accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 87 doctors at Mount Sinai Morningside who specialize in Oncology. He has more than 100 publications and over 500 citings.

Office
222 East 70th Street
New York, NY 10021
Book by Phone+1(424) 285-1384

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1982 - 1985
Harvard Medical SchoolClass of 1982

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 1984 - 2027
CT State Medical License 2023 - 2025
NJ State Medical License 2012 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2003-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Elected Member The American Society for Clinical Investigation, 2000
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers Start of enrollment: 1994 Dec 01
Active, not recruiting
Clinical Significance of Germline BRCA Mutations Start of enrollment: 1996 Jul 01
Active, not recruiting
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients Start of enrollment: 2000 Mar 01
Active, not recruiting
Not Applicable
Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging Start of enrollment: 2006 Sep 01
Completed
Identification of New Colorectal Cancer Genes Start of enrollment: 1998 Feb 10
Completed
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders Start of enrollment: 2000 Jul 01
Recruiting
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer Start of enrollment: 2000 Jul 01
Withdrawn
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer Start of enrollment: 1997 Mar 01
Completed
BRCA Founder OutReach (BFOR) Study Start of enrollment: 2017 Nov 10
Active, not recruiting
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer Start of enrollment: 2019 Apr 17
Recruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk Start of enrollment: 2022 Dec 01
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer.
Konrad H Stopsack, Joseph Vijai, Michael Conry, Jacob E Berchuck, Yelena Kemel
Clinical Cancer Research. 2024-10-25
1 citations
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.
Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy
Haematologica. 2024-10-01
1 citations
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
Heather H Cheng, Jeffrey W Shevach, Elena Castro, Fergus J Couch, Susan M Domchek
JAMA Oncology. 2024-09-01

Journal Articles

Toward Automation of Germline Variant Curation in Clinical Cancer Genetics
Steven Lipkin, Karen Cadoo, Mark Robson, Kenneth Offit, Liying Zhang, Zsofia Stadler, Diana Mandelker, Nature
Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): Lessons Learned and Plans for the Future
Heidi L Rehm, Ray E Hershberger, Meredith A Weaver, Birgit H Funke, Rong Mao, Kenneth Offit, William J Craigen, Sharon E Plon, Jonathan S Berg, Nature
The Genomics ADvISER: Development and Usability Testing of a Decision Aid for the Selection of Incidental Sequencing Results
Jada G Hamilton, Mark Robson, Kenneth Offit, Nature
Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility Locus
Susan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature
Join now to see all

Lectures

Genomics and Cancer Prevention
2013 Annual Meeting, Chicago, Illinois, USA
Genomics and Cancer Prevention
American Society of Clinical Oncology, 2013 Annual Meeting, Chicago, Illinois, USA

Press Mentions

Survivor’s Story Foreshadows One of Oncology’s Greatest SuccessesApril 14th, 2022
How Do Inherited Gene Mutations Cause Cancer? A New Database Will Help Researchers Find OutNovember 5th, 2021
Cancer Therapy Shapes the Fitness Landscape of Clonal HematopoiesisOctober 26th, 2020
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment